Jun 14, 2024, 09:30
Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research
The START Center for Cancer Research shared on LinkedIn: .
“Don’t miss our upcoming webinar, “Overcoming Resistance: Enhancing CDK4/6 Inhibitor Efficacy in Advanced Breast Cancer Treatment”, on July 9th at 3 PM ET.
Led by Michael Wick, Chief Scientific Officer at XenoSTART, this session will cover:
– Key insights into FDA-approved CDK4/6 inhibitors
– Mechanisms of resistance in ER+ breast cancer
– Strategies for re-sensitizing resistant patients through combination therapy
Register today.”
Source: The START Center for Cancer Research/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29
Nov 13, 2024, 15:25
Nov 13, 2024, 14:55
Nov 13, 2024, 14:47
Nov 13, 2024, 14:43
Nov 13, 2024, 14:37
Nov 13, 2024, 14:05